OSTEOEZE ONE-A-DAY

Valsts: Austrālija

Valoda: angļu

Klimata pārmaiņas: Department of Health (Therapeutic Goods Administration)

Aktīvā sastāvdaļa:

glucosamine sulfate sodium chloride, Quantity: 1.884 g (Equivalent: glucosamine sulfate, Qty 1.5 g); ascorbic acid, Quantity: 48.71 mg (Equivalent: ascorbic acid, Qty 45 mg); magnesium phosphate tribasic, Quantity: 210 mg (Equivalent: magnesium, Qty 42 mg)

Pieejams no:

Orion Laboratories Pty Ltd T/A Perrigo Australia

SNN (starptautisko nepatentēto nosaukumu):

Ascorbic acid,glucosamine sulfate sodium chloride,magnesium phosphate tribasic

Zāļu forma:

Tablet, film coated

Kompozīcija:

Excipient Ingredients: magnesium stearate; povidone; hypromellose; tartaric acid; microcrystalline cellulose; titanium dioxide; macrogol 8000; glucose monohydrate; maltodextrin; carmellose sodium; lecithin

Ievadīšanas:

Oral

Ārstēšanas norādes:

Helps decrease/reduce/relieve cartilage loss/wear/tear/damage ; Aid/assist/helps connective tissue production/formation ; Decrease/reduce/relieve symptoms of mild arthritis/mild osteoarthritis (Linked Indication:Decrease/reduce/relieve mild joint aches and pains; Helps maintain/supports healthy joint cartilage growth/development/production; Helps enhance/improve/promote joint mobility); Helps maintain/support joint cartilage health ; Helps enhance/promote healthy joint function ; Helps enhance/promote joint health ; Maintain/support joint health ; Maintain/support joint mobility/flexibility ; Decrease/reduce/relieve mild joint pain/soreness

Produktu pārskats:

Visual Identification: ;

Autorizācija statuss:

Licence status A

Autorizācija datums:

2017-09-20